Molecular Profile | Unknown unknown |
Therapy | GANT61 |
Indication/Tumor Type | colon cancer |
Response Type | not applicable |
Create By | stafford |
Update By | smockus |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References | Unknown unknown | colon cancer | not applicable | GANT61 | Preclinical | Actionable | In a preclinical study, treatment with the GLI1/GLI2 inhibitor, GANT61, resulted in cytotoxicity in colon cancer cell lines (PMID: 21135115). | 21135115 |
---|
PubMed Id | Reference Title | Details |
---|---|---|
(21135115) | Hedgehog signaling drives cellular survival in human colon carcinoma cells. | Full reference... |